VivaQuity: Benefits of non-surgical dietary supplements for floaters

In a new publication, an international team of researchers confirmed the impact of targeted nutritional intervention via supplementation for patients suffering from vitreous floaters. The double-blind, placebo-controlled, monocentric 'Floater Invention Study', FLIES, examined subjects of all ages over a period of 6 months and was able to demonstrate significant improvements in subjective visual disturbances as well as in the objective parameters 'vitreous opacity density' and 'contrast sensitivity'.

The success rate among the subjects was 77% for the objective improvements (reduction of floater opacity areas) and 67% for the subjective ones (complaint score).

The tested product in the FLIES study was VitroCap N, which is available in the USA under the trademark VitreousHealth.